All certificates of analysisSemaglutide 30mg product page

Semaglutide 30mg

Results reported for the submitted sample

Semaglutide 30mg

Lot in our record: SEM-20260828-01
Certificate ID: COA8900
Lot printed on the certificate: SEM-20260828-01

Bioviridian Inc. · COA8900

Reported identity: Semaglutide; LC-MS/MS
Measured content / assay: 31.38 mg; HPLC Quantitation
Chromatographic purity: 99.78%; RP-HPLC (214 nm)

Testing scope

Results are reported for the submitted sample. They do not establish the identity or composition of every vial carrying a lot label.

We have not commissioned sterility or endotoxin testing for this material. This is the owner's statement about Purely Peptides' commissioning, not a claim about testing by upstream parties.

This report does not include a residual-solvent result.

These results do not establish suitability for human or veterinary use.

Independent issuer confirmation has not been recorded for this assessment. A hosted PDF or report code does not establish authenticity or physical-sample linkage.

Additional laboratory results (2)

Krause Analytical LLC · sample muz22ts · Lab #214175

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code muz22ts. We list this result under lot SEM-20260828-01.

Chromatographic purity: 98.8%; Method: HPLC-UV/MS
Measured content: 32.3 mg; Method: HPLC-UV-MS
Identity (mass spectral match): ID Confirmed; Method: HPLC-UV-MS
Label claim: 30 mg
% of label, as printed: 107.8
COC#: 145871
Received: 2026-09-18
Analyzed: 2026-09-25
Report issued: 2026-10-01
Laboratory address: 8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director: Mark C. Krause
PDF SHA-256: 5eb1ffa5d911590d5bc29e05ed565ae05c9aa686243d94cd1e26985ce38efb21

Original full certificate (PDF) · muz22ts

Krause Analytical LLC · sample tes8zb2 · Lab #214174

Tested by Krause Analytical LLC; commissioned through Finnrick.

The certificate’s Batch/Lot field shows the Finnrick sample code tes8zb2. We list this result under lot SEM-20260828-01.

Chromatographic purity: 98.6%; Method: HPLC-UV/MS
Measured content: 33.4 mg; Method: HPLC-UV-MS
Identity (mass spectral match): ID Confirmed; Method: HPLC-UV-MS
Label claim: 30 mg
% of label, as printed: 111.5
COC#: 145871
Received: 2026-09-18
Analyzed: 2026-09-25
Report issued: 2026-10-01
Laboratory address: 8127 Mesa Drive Suite B-206, Austin, TX 78759
Laboratory director: Mark C. Krause
PDF SHA-256: ef454a2fb5468879a483654c6467965589e6edcf60eeca408874d536ec400d6d

Original full certificate (PDF) · tes8zb2

Original certificate (PDF)Read about analytical terms

Issuer and report details

Bioviridian Inc. is named on the certificate as the issuing laboratory. Independent issuer confirmation has not been recorded for this assessment (not checked).

Check the report with the issuing laboratory

Use certificate ID COA8900. Issuer confirmation would not by itself establish all-vial or physical-sample linkage.

Methods, reporting context and disclosure provenance

Sample type: White lyophilized powder
Molecular weight (g/mol), as recorded: 4113.7
Sample received: 2026-09-03
Report issued: 2026-09-08
HPLC retention time, as recorded: 11.536 min

Results and methods retain the report record's original units and precision. A result here is not a finding that an acceptance specification was met.

Source: page 1, Test Results, Sample Information and Analytical Methods. Document annotations were visually inspected on 2026-10-10; no new laboratory authentication has been performed.

Commissioning disclosure: Purely Peptides owner's statement in the editorial and batch-results brief, bound to this inspected report and material. It is separate from document-derived absence of a residual-solvent result.

Published by Purely Peptides, a commercial research-material supplier. These documentation pages do not establish suitability for human or veterinary use.